ERBB2 and diabetes mellitus: This was more obvious in the case of acute ex vivo studies where a marked reduction in ErbB2 phosphorylation, with little change in total receptor protein, was noted upon Ang-(1–7) treatment compared to diabetes alone (Fig 3a panel i).